FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

22980611000001104: Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 18-Sep 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1849301000001118 Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1849321000001113 Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) Is a Ondansetron 2mg/mL injection solution 2mL ampule false Inferred relationship Existential restriction modifier
Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) Has active ingredient Ondansetron true Inferred relationship Existential restriction modifier
Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) Has manufactured dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) Has specific active ingredient Ondansetron hydrochloride true Inferred relationship Existential restriction modifier
Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ondansetron true Inferred relationship Existential restriction modifier
Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) Has basis of strength substance Ondansetron true Inferred relationship Existential restriction modifier
Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) Is a Ondansetron 4mg/2ml solution for injection ampoules false Inferred relationship Existential restriction modifier
Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) Is a Ondansetron 4mg/2ml solution for injection ampoules true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) 5 ampoule Has AMP True Ondansetron 4mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start